Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Association of FGFR2 structural alterations in intrahepatic cholangiocarcinomas with female gender and younger age.
Authors
Zishuo Ian Hu
Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Zishuo Ian Hu , Jeffrey S. Ross , Dean C. Pavlick , David Hsieh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 537)
DOI
10.1200/JCO.2024.42.3_suppl.537
Abstract #
537
Poster Bd #
F4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomic characterization of unresectable/recurrent early-onset gastric cancer by comprehensive genomic profiling tests.
First Author: Kunihito Matsuguma
Poster
2023 ASCO Annual Meeting
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
First Author: Subotheni Thavaneswaran
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco